The genetics of vasculitides;Genetischer Hintergrund der Vaskulitiden

Zeitschrift fur Rheumatologie

Volumn 70, Issue 3, 2011, Pages 198-204

  Holle, J U ^a   Wieczorek, S ^a   Epplen, J T ^a   Gross, W L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ANCA associated vasculitides; Beh et's disease; Candidate genes; Genomwide association study; Kawasaki syndrome; Large vessel vasculitides

Indexed keywords

ALPHA 1 ANTITRYPSIN; HLA DPB1 ANTIGEN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ALLELE; ARTICLE; BEHCET DISEASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; MUCOCUTANEOUS LYMPH NODE SYNDROME;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; VASCULITIS;

EID: 79960007963     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-010-0692-3     Document Type: Article

References (27)

1. Arning L, Holle JU, Harper L et al (2010) Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis? Ann Rheum Dis [Epub ahead of print Aug 10]
2. Ayesh S, Abu-Rmaileh H, Nassar S et al (2008) Molecular analysis of MEFV gene mutations among Palestinian patients with Behcet's disease. Scand J Rheumatol 37:370-374
3. Ben Dhifallah I, Houman H, Khanfir M et al (2008) Endothelial nitric oxide synthase gene polymorphism is associated with Behcet's disease in Tunsisian population. Hum Immunol 69:661-665
4. Burgner D, Davila S, Breunis WB et al (2009) A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 5:e1000319
5. Carr EJ, Niederer HA, Williams J et al (2009) Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis. BMC Med Genet 10:121
6. Dursun A, Durakbasi-Dursun HG, Dursun R et al (2009) Angiotensin- converting enzyme gene and endothelial nitric oxide synthase gene polymorphism in Behcet's disease with or without ocular involvement. Inflamm Res [Epub ehead of print Mar 3]
7. Esnault VL, Testa A, Audrian M et al (1993) Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 43:1329-1332 (Pubitemid 23161420)
8. Fei Y, Webb R, Cobb BL et al (2009) Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide associaction study. Arthritis Res Ther 11:R66
9. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C et al (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatic. Semin Arthritis Rheum 33:38-48 (Pubitemid 37046580)
10. Heckmann M, Holle JU, Arning L et al (2008) The Wegener's granulomatosis quantative trait locus on chromosome 6p21.3 as characterized by tagSNP genotyping. Ann Rheum Dis 67:972-979 (Pubitemid 351956660)
11. Imirzalioglu N, Dursun A, Tastan B et al (2005) MEFV gene is a probable susceptibility gene for Behcet's disease. Scand J Rheumatol 34:56-58 (Pubitemid 40445060)
12. Jagiello P, Gencik M, Arning L et al (2004) New genomic region for Wegener's granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum Genet 114:468-477 (Pubitemid 38678925)
13. Jagiello P, Aries P, Arning L et al (2005) The PTPN22 620 W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 12:4039-4043 (Pubitemid 41798244)
14. Krause I, Weinberger A (2008) Behcet's disease. Curr Opin Rheumatol 20:82-87
15. Mahr AD, Edberg J, Stone J et al (2009) Alpha 1-antitrypsin deficiency and the risk for Wegener's granulomatosis. In: Proceedings of the 14th International Vasculitis and ANCA Workshop. APMIS 117(Suppl 127):157 [abstract N1]
16. Monach P, Merkel PA (2010) Genetics of vasculitis. Curr Opin Rheumatol 22:157-163
17. Rarok AA, Stegeman CA, Limburg PC et al (2002) Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA associated vasculitis. J Am Soc Nephrol 13:1224-1233
18. Stassen PM, Cohen-Tervaert JW, Leemsp SP et al (2009) HLA-DR4, DR13(6) and the ancestral haplotype A1 B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis. Rheumatology 48:622-625
19. Szodoray P, Szabo Z, Kapitány A et al (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimm Rev 9:140-143
20. Vaglio A, Martorana D, Maggiore U et al (2007) HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Arthritis Rheum 56:3159-3166 (Pubitemid 47502764)
21. Vargas-Alacron G, Hernandez-Pacheco G, Soto ME et al (2005) Comparative study of the residues 63 and 67 on the HLA-B molecule in patients with Takayasu's arteritis. Immunol Lett 96:225-229 (Pubitemid 39600779)
22. Wieczorek S, Hellmich B, Arning L et al (2008) Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome. Arthritis Rheum 58:1839-1848 (Pubitemid 351847539)
23. Wieczorek S, Hellmich B, Gross WL et al (2008) Associations of Churg-Strauss syndrome with the HLA-DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody-associated vasculitides: comment on the article by Vaglio et al. Arthritis Rheum 58:329-330
24. Wieczorek S, Holle JU, Epplen JT (2010) Recent progress in the genetics of Wegener's granulomatosis and Churg-Strauss syndrome. Curr Opin Rheumatol 22:8-14
25. Wieczorek S, Holle JU, Müller S et al (2010) A functionally relevant IRF5 haplotype is associated with reduced risk to Wegener's granulomatosis. J Mol Med 88:413-421
26. Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35-42
27. De Menthon M, Lavalley MP, Maldini C et al (2009) HLA-B51/B5 and the risk of Behcet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 61:1287-1296